Buprenorphine-induced acute respiratory depression during ifosfamide-based chemotherapy.
Moro
C
C
Taino
R
R
Mandalà
M
M
Labianca
R
R
D000208:Acute Disease; D000328:Adult; D000701:Analgesics, Opioid / Q000009:adverse effects; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D002047:Buprenorphine / Q000009:adverse effects*; D006801:Humans; D007069:Ifosfamide / Q000627:therapeutic use*; D008297:Male; D012516:Osteosarcoma / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D010146:Pain / Q000150:complications / Q000188:drug therapy; D010386:Pelvic Neoplasms / Q000150:complications / Q000188:drug therapy / Q000556:secondary; D012131:Respiratory Insufficiency / Q000139:chemically induced* / Q000209:etiology; D012888:Skull Neoplasms / Q000150:complications / Q000188:drug therapy / Q000601:surgery
D000701:Analgesics, Opioid; D018906:Antineoplastic Agents, Alkylating; D002047:Buprenorphine; D007069:Ifosfamide